Welcome to CFSRE’s interactive NPS Discovery dashboard, a tool that allows for customized generation of NPS results based on analyte, class, and demographics. This tool has been created to assist practitioners, researchers, public health officials and other notable stakeholders who are searching for real-time and actionable data. The below interface allows the user to monitor NPS emergence, track NPS proliferation, and much more.

The data in this dashboard are derived from the analysis of de-identified biological sample extracts from forensic investigations received at NMS Labs. This includes casework from medicolegal death investigations and human performance toxicology testing. At CFSRE, the de-identified extracts were analyzed using comprehensive high resolution mass spectrometry (HRMS) workflows for the non-targeted detection of NPS (for more information about our workflows, check out our recent presentations at AAFS and ASMS), as well as traditional drugs of abuse, therapeutic drugs, and cutting agents. In total, these workflows contain more than 700 analytes and are generally updated on a weekly to monthly basis based on the discovery of new NPS in the United States and information from other NPS intelligence sources.

Instructions:

1. Select a category to view using the dropdown menu under “Data Selection.”
2. Select a date range under the “Date” heading.
3. Select how many analytes you would like to view within the results windows using the “Max Number to Show” box under the “Compound” heading.
4. (If Applicable) Select a specific NPS to display under “Compound” or a specific NPS class under “Type.” If you click in each field, a list of options will appear. You may scroll through the list and select the entry you are looking for or you may begin typing the name of the entry you are looking for. Be sure to remove (backspace) the [*] from the input boxes that you change, as this entry signifies “all entries.”

Note: As you change the input features of the dashboard, the new data will automatically populate. To revert the dashboard back to original, reload or refresh the webpage

Acknowledgements: The data housed within this dashboard was generated using sample extracts received from NMS Labs and under support funded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (Award Numbers 2017-R2-CX-0002 and 2017-R2-CX-0021). The opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the Department of Justice.Disclaimer: The data displayed in this dashboard represents a subset of the samples submitted to NMS Labs at a given time point. Demographic breakdown and/or geographical distribution may be limited by location of agencies submitting samples or other factors and may not necessarily represent all jurisdictions and/or drug using populations.

Disclaimer: The data displayed in this dashboard represent a subset of the samples submitted to NMS Labs at a given time point. Demographic breakdown and/or geographical distribution may be limited by location of agencies submitting samples and/or other factors and will not necessarily represent all jurisdictions and/or drug using populations.

If you would like to include any of the information in this dashboard as part of a publication or report, please contact us (npsdiscovery@frfoundation.org) for more information and/or additional background on how the data was collected, complied, and generated.